Pure Global AI
NCT05794022Recruiting

Cohort of STEMI Patients 2

CoHort of Patients to Identify Biological and Imaging markerS of CardiovascUlar Outcomes in ST Elevation Myocardial Infarction
Hospices Civils de LyonClinicalTrials.govother
Verified
Study focus
Disease/Condition
Myocardial Infarction
Drug/Device/Intervention
MRI
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Hospices Civils de Lyon
Location
Bron,Lyon, France
Timeline & enrollment
Phase
N/A
Start date
May 03, 2023
End date
Jun 03, 2029
Enrollment
100 participants
Primary outcome

Research of potential new markers

Summary

ST-segment elevation myocardial infarction (STEMI) is an acute condition that accounts for
 75% of sudden deaths in adults over 35 years of age and more than half of all cases of
 chronic heart failure. However, the mechanism of myocardial infarction remains poorly
 understood. At present, there is no national information system for myocardial infarction, as
 there is for other diseases such as multiple sclerosis (OFSEP cohort).
 
 The purpose of this cohort is to enable studies and research projects to be carried out on
 the descriptive epidemiology of myocardial infarction, monitoring of patients undergoing
 treatment (safety, efficacy), quality of life and functional consequences of infarction, and
 research into new biological and imaging prognostic biomarkers. Its general objective is to
 provide researchers, hospital practitioners, medical interns, academics or industrialists
 with a quality epidemiological tool for research.

ICD-10 classifications
Acute myocardial infarctionAcute myocardial infarction, unspecifiedOld myocardial infarctionSubsequent myocardial infarctionObservation for suspected myocardial infarction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05794022
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05794022 through Pure Global AI's free database. This phase not specified trial is sponsored by Hospices Civils de Lyon and is currently Recruiting. The study focuses on Myocardial Infarction. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.